Sumithran, Priya

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3,163

Definition and diagnostic criteria of clinical obesity

Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., et al. (2025) · The Lancet Diabetes & Endocrinology

Obesity and Health PracticesObesity, Physical Activity, Diet

Cited by 1,811

Long-term persistence of hormonal adaptations to weight loss

Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2011) · New England Journal of Medicine

Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases

Cited by 1,449

Contemporary medical, device, and surgical therapies for obesity in adults

Perdomo, C. M., Cohen, R. V., Sumithran, P., Clément, K., & Frühbeck, G. (2023) · The Lancet

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 738

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 638

Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation

Lingvay, I., Sumithran, P., Cohen, R. V., & le Roux, C. W. (2022) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 581

Obesity in adults

Lingvay, I., Cohen, R. V., Roux, C. W. L., & Sumithran, P. (2024) · The Lancet

Bariatric Surgery and OutcomesPharmacology and Obesity Treatment

Cited by 433

The defence of body weight: a physiological basis for weight regain after weight loss

Sumithran, P., & Proietto, J. (2013) · Clinical Science

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 310

The effect of rate of weight loss on long-term weight management: a randomised controlled trial

Purcell, K., Sumithran, P., Prendergast, L. A., Bouniu, C. J., Delbridge, E., & Proietto, J. (2014) · The Lancet Diabetes & Endocrinology

Obesity, Physical Activity, DietPharmacology and Obesity Treatment

Cited by 201

Treatment of obesity in older persons—A systematic review

Haywood, C., & Sumithran, P. (2019) · Obesity Reviews

Bariatric Surgery and OutcomesPharmacology and Obesity Treatment

Cited by 84

Association between glucagon-like peptide-1 receptor agonist use and peri-operative pulmonary aspiration: a systematic review and meta-analysis

Castrillon, J., Rele, S., Sumithran, P., Hii, M., Thuraisingam, S., Spelman, T., Phan, T., Choong, P., Dowsey, M., & Shadbolt, C. (2025) · Anaesthesia

Enhanced Recovery After SurgeryAirway Management and Intubation Techniques

Cited by 65

The therapeutic potential of GLP-1 analogues for stress-related eating and role of GLP-1 in stress, emotion and mood: a review

Guerrero-Hreins, E., Goldstone, A. P., Brown, R. M., & Sumithran, P. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Regulation of Appetite and ObesityEating Disorders and Behaviors

Cited by 62

Potential gut–brain mechanisms behind adverse mental health outcomes of bariatric surgery

Brown, R. M., Guerrero-Hreins, E., Brown, W. A., le Roux, C. W., & Sumithran, P. (2021) · Nature Reviews Endocrinology

Bariatric Surgery and OutcomesGut microbiota and health

Cited by 49

Change in Emotional Eating After Bariatric Surgery: Systematic Review and Meta-Analysis

Wong, L. Y., Zafari, N., Churilov, L., Stammers, L., Price, S., Ekinci, E. I., & Sumithran, P. (2020) · BJS Open

Bariatric Surgery and OutcomesEating Disorders and Behaviors

Cited by 29

Gut-Brain Mechanisms Underlying Changes in Disordered Eating Behaviour After Bariatric Surgery: A Review

Guerrero-Hreins, E., Foldi, C. J., Oldfield, B. J., Stefanidis, A., Sumithran, P., & Brown, R. M. (2022) · Reviews in Endocrine and Metabolic Disorders

Bariatric Surgery and OutcomesEating Disorders and Behaviors

Cited by 21

Risk of diabetes with statins

Mansi, I. A., Sumithran, P., & Kinaan, M. (2023) · BMJ

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 20

Obesity drug shortages are symptomatic of wider malaise

Sumithran, P., Finucane, F. M., & Cohen, R. V. (2024) · The Lancet

Pharmacology and Obesity TreatmentPharmaceutical Economics and Policy

Cited by 16

There is no magic bullet for obesity

Lingvay, I., Sumithran, P., le Roux, C. W., & Cohen, R. V. (2023) · The Lancet Diabetes & Endocrinology

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 16